News
Health officials want you to think twice before buying one of those brightly colored little bottles often sold at gas ...
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
And there is no F.D.A. requirement for a fatty acid called docosahexaenoic acid, or DHA, which is important for brain ...
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
The dangers of synthetic food dyes aren’t new news. A 2021 California report tied them to hyperactivity and behavioral issues ...
RAD101 in U.S. Phase 2 clinical trial to distinguish between recurrent disease and treatment effect of brain metastases ...
Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results